uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure

On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease (CNMD) welcomed researchers, trainees and staff to celebrate the research centre’s 25th anniversary.

Founded in 1999 by Dr Bernard Jasmin and Dr Rashmi Kothary, the CNMD has flourished as an interdisciplinary hub of cutting-edge science, evolving into a research hotbed that’s earned a global reputation as a talent-rich innovator, uniting ambitious and talented researchers from the University of Ottawa, The Ottawa Hospital, Ottawa Hospital Research Institute, University of Ottawa Heart Institute, Children’s Hospital of Eastern Ontario (CHEO), and the CHEO Research Institute.

The event highlighted the current groundbreaking neuromuscular research being conducted by investigators at the CNMD and celebrated the enormous growth and international achievements of the CNMD under former co-directors Dr Jodi Warman-Chardon and Dr Robin Parks. The celebration also ushered in the new leadership tenure of Dr Mireille Khacho and Dr Hanns Lochmüller, who see the coming years as a galvanizing time for the field of neuromuscular disease research and view the Centre’s broad community as poised to lead the way. Here’s to another 25 years of research excellence at the CNMD!

Read the full news item from the University of Ottawa Faculty of Medicine

Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

Read next...

award winners

Celebrating Lab Members’ Recent Research Awards

We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
New publication - RTD (2)

Meet The Lochmüller Lab’s Newest Members!

Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
McMillan smart study (1)

New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort

Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...
Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...